Information for industry
- FDA released the Biosimilars Action Plan (PDF, 383 KB) to provide information about the key actions the agency is taking to encourage innovation and competition among biologics and the development of biosimilars. (July 18, 2018)
- Reminder: Comments are due on the draft guidance for industry, Smallpox (Variola Virus) Infection: Developing Drugs for Treatment or Prevention (PDF, 120 KB) by September 10, 2018.
No hay comentarios:
Publicar un comentario